Bioverativ
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Bioverativ and buy or sell other stocks, ETFs, and their options commission-free!About BIVV
Bioverativ, Inc. is a global biopharmaceutical company, focused on discovery, research, development and commercialization of therapies for the treatment of blood diseases including hemophilia. The company is headquartered in Cambridge, MA.
CEOJohn G. Cox, MBA
CEOJohn G. Cox, MBA
Employees—
Employees—
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2017
Founded2017
Employees—
Employees—
BIVV Key Statistics
Market cap11.36B
Market cap11.36B
Price-Earnings ratio32.01
Price-Earnings ratio32.01
Dividend yield—
Dividend yield—
Average volume3.24M
Average volume3.24M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$105.01
52 Week high$105.01
52 Week low$48.14
52 Week low$48.14
Stock Snapshot
With a market cap of 11.36B, Bioverativ(BIVV) trades at $104.65. The stock has a price-to-earnings ratio of 32.01.
On 2025-12-10, Bioverativ(BIVV) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Bioverativ(BIVV) stock has reached 0, versus its average volume of 3.24M.
Over the past 52 weeks, Bioverativ(BIVV) stock has traded between a high of $105.01 and a low of $48.14.
Over the past 52 weeks, Bioverativ(BIVV) stock has traded between a high of $105.01 and a low of $48.14.